Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of care for stage III non-small cell lung cancer in Australia.
Parente P, Chan BA, Hughes BGM, Jasas K, Joshi R, Kao S, Hegi-Johnson F, Hui R, McLaughlin-Barrett S, Nordman I, Stone E. Parente P, et al. Asia Pac J Clin Oncol. 2019 Jun;15(3):93-100. doi: 10.1111/ajco.13140. Epub 2019 Mar 14. Asia Pac J Clin Oncol. 2019. PMID: 30868747 Review.
Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia.
Hau E, Hegi-Johnson F, Atkinson C, Barber J, Browne LH, Chin Y, Dwyer P, Graham PH, O'Hare J, Lu D, Rains M, Ragusa C, Schmidth L, Small K, Unicomb K, West K, White S, Last A, Ludbrook J, Azzi M, Aherne NJ, Van Tilburg K, Vinod S, Ma X, Yeghiaian Alvandi R. Hau E, et al. Asia Pac J Clin Oncol. 2020 Feb;16(1):39-44. doi: 10.1111/ajco.13277. Epub 2019 Nov 27. Asia Pac J Clin Oncol. 2020. PMID: 31777176 Clinical Trial.
Overcoming immunotherapy resistance in NSCLC.
MacManus M, Hegi-Johnson F. MacManus M, et al. Lancet Oncol. 2022 Feb;23(2):191-193. doi: 10.1016/S1470-2045(21)00711-7. Epub 2022 Jan 13. Lancet Oncol. 2022. PMID: 35033225 No abstract available.
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Hegi-Johnson F, Rudd SE, Wichmann C, Akhurst T, Roselt P, Trinh J, John T, Devereux L, Donnelly PS, Hicks R, Scott AM, Steinfort D, Fox S, Blyth B, Parakh S, Hanna GG, Callahan J, Burbury K, MacManus M. Hegi-Johnson F, et al. BMJ Open. 2022 Nov 18;12(11):e056708. doi: 10.1136/bmjopen-2021-056708. BMJ Open. 2022. PMID: 36400733 Free PMC article. Clinical Trial.
Australia and New Zealand Faculty of Radiation Oncology Lung Interest Cooperative: 2015 consensus guidelines for the use of advanced technologies in the radiation therapy treatment of locally advanced non-small cell lung cancer.
Dwyer PM, Lao L, Ruben JD, Yap ML, Siva S, Hegi-Johnson F, Hardcastle N, Barber J, Lehman M, Ball D, Vinod SK. Dwyer PM, et al. J Med Imaging Radiat Oncol. 2016 Oct;60(5):686-692. doi: 10.1111/1754-9485.12501. Epub 2016 Jul 28. J Med Imaging Radiat Oncol. 2016. PMID: 27470188 No abstract available.
Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC.
MacManus M, Kirby L, Blyth B, Banks O, Martin OA, Yeung MM, Plumridge N, Shaw M, Hegi-Johnson F, Siva S, Ball D, Wong SQ. MacManus M, et al. Among authors: hegi johnson f. Clin Transl Radiat Oncol. 2023 Sep 22;43:100682. doi: 10.1016/j.ctro.2023.100682. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37808452 Free PMC article.
30 results